These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24382070)

  • 21. Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study.
    Badreldin H
    J Thromb Thrombolysis; 2018 Jul; 46(1):16-21. PubMed ID: 29626281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dabigatran versus warfarin for venous thromboembolism.
    Teachey DT
    N Engl J Med; 2010 Mar; 362(11):1050; author reply 1050-1. PubMed ID: 20301800
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of venous thromboembolisms].
    Wagner W
    Med Klin (Munich); 2010 Sep; 105(9):674; author reply 675. PubMed ID: 20878306
    [No Abstract]   [Full Text] [Related]  

  • 25. Direct oral anticoagulants for venous thromboembolism treatment and prophylaxis.
    Yorkgitis BK
    JAAPA; 2016 Aug; 29(8):24-9. PubMed ID: 27359069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of warfarin and new anticoagulants.
    Adam SS; Ortel TL; Williams JW
    Ann Intern Med; 2013 Apr; 158(8):637-8. PubMed ID: 23588759
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative effectiveness of warfarin and new anticoagulants.
    Reiffel JA
    Ann Intern Med; 2013 Apr; 158(8):637. PubMed ID: 23588758
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative effectiveness of warfarin and new anticoagulants.
    Trowbridge RL; Smith KE
    Ann Intern Med; 2013 Apr; 158(8):636-7. PubMed ID: 23588757
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral apixaban for the treatment of acute venous thromboembolism.
    Agnelli G; Buller HR; Cohen A; Curto M; Gallus AS; Johnson M; Masiukiewicz U; Pak R; Thompson J; Raskob GE; Weitz JI;
    N Engl J Med; 2013 Aug; 369(9):799-808. PubMed ID: 23808982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period.
    Deitcher SR; Kessler CM; Merli G; Rigas JR; Lyons RM; Fareed J;
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):389-96. PubMed ID: 17000884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dabigatran versus warfarin in the treatment of acute venous thromboembolism. Results of the RE-COVER study].
    Liakishev AA
    Kardiologiia; 2010; 50(3):80-1. PubMed ID: 20459411
    [No Abstract]   [Full Text] [Related]  

  • 32. Underutilization of anticoagulant for venous thromboembolism prophylaxis in three hospitals in Jakarta.
    Atmakusuma TD; Tambunan KL; Sukrisman L; Effendi S; Rachman A; Setiawati A; Rinaldi I; Mulansari NA; Rajabto W; Nasution SA; Muhadi ; Aninditha T; Sedono R; Sugiarto A; Pitoyo CW; Paramitha D; Astoro NW; Nasution IR
    Acta Med Indones; 2015 Apr; 47(2):136-45. PubMed ID: 26260556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage.
    Shoji T; Mizugaki H; Ikezawa Y; Furuta M; Takashima Y; Kikuchi H; Goudarzi H; Asahina H; Kikuchi J; Kikuchi E; Sakakibara-Konishi J; Shinagawa N; Tsujino I; Nishimura M
    Intern Med; 2018 Jun; 57(12):1769-1772. PubMed ID: 29434159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation prescribing patterns in patients with cancer.
    Xiang E; Ahuja T; Raco V; Cirrone F; Green D; Papadopoulos J
    J Thromb Thrombolysis; 2018 Jan; 45(1):89-98. PubMed ID: 29052104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.
    Marcy TR; Truong T; Rai A
    Consult Pharm; 2015 Nov; 30(11):644-56. PubMed ID: 26629800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States.
    Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
    Clin Appl Thromb Hemost; 2016 Jan; 22(1):5-11. PubMed ID: 25993994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer.
    Di Nisio M; Rutjes AW
    Evid Based Med; 2016 Apr; 21(2):66. PubMed ID: 26786824
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan.
    Nakamura M; Yamada N; Ito M
    J Atheroscler Thromb; 2017 Jun; 24(6):560-565. PubMed ID: 28392512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM; Silva MA; Donovan JL; Kanaan AO
    Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.